PK-VS In-line SVP, Blow Fill Seal CCI Tester


Non-Invasive, Non-Destructive, 100% in-line Integrity Inspection at high production speed

icon-01 PLAY VIDEO



IV Bags



  • Autotest in real time
  • Easy to validate
  • CFR 21 part 11 compliance and 4.0 full integration
  • Quick format changeover
  • Automatic Drying System, no testing chamber contamination

Technical Features

  • Container Application: Small Volume Parenteral, Blow fill Seal (PK-VS SVP)
  • Products: Liquid
  • Container Dimensions: min: 40 x 40 x 6 mm; max: 150 x 80 x 15 mm
  • Speed: Up to 220 strip/BFS or cards per minute
  • Technology: CCIT
  • Inspection Features: Non-Invasive, Non-Destructive CCIT based on Vacuum Decay Method
  • Inspection Capabilities: Microleaks detection

Additional Benefits

  • Full batch control testing: fast, reliable and repeatable
  • Testing of all nominal production line speed
  • MES (Manufacturing Execution System connection) allows remote machine data exchange & download
  • Statistical Process Control reduces deviations for a better yield control
  • Real time display of testing cycle diagrams, statistical raw data
  • Easy, quick and safe remote access
  • AHE (Automatic Head Exclusion)
  • Easy cleaning


  • Container Closure Integrity Testing is a non-destructive measurement technology based on Vacuum Decay Method.
  • Measurement system comprises applying a pressure differential into an airtight testing group enclosing the container.
  • The test objective is to detect container leakages by measuring the reached vacuum level as well as the vacuum change over test time.

Quality Assurance

  • Equipment test method refers to:
  • Approved industry standard “ASTM F2338-09”: “Standard Test Method for Non-Destructive Detection of Leaks in Packages”
  • United States Pharmacopoeia – USP General Chapter «1207» “Packaging Integrity Evaluation”
  • EU Guidelines to GMP Medicinal Products for Human and Veterinary Use – Annex 1 “Manufacture of Sterile Medicinal Products”
  • PDA Technical Report No. 27 “Pharmaceutical Package Integrity”
  • FDA 21 CFR part 11 as well as EMA Annex 11

Learn more about this product